Thymosin Alpha-1 has been used for decades in medical settings to support immune response in immunocompromised patients, including those with chronic infections, cancer, and viral illnesses. Its primary mechanism is enhancing T-cell maturation and differentiation by binding to Toll-Like Receptors (TLR3/4/9) on immune cells, stimulating Th1 cytokines (IL-2, IFN-gamma), and effectively reversing immune suppression.